促性腺激素释放激素激动剂联合放置左炔诺孕酮宫内缓释系统治疗子宫腺肌病的效果.docVIP

促性腺激素释放激素激动剂联合放置左炔诺孕酮宫内缓释系统治疗子宫腺肌病的效果 　　【摘 要】目的：探究对子宫腺肌病患者应用促性腺激素释放激素激动剂联合放置左炔诺孕酮宫内缓释系统治疗方式实施救治的临床诊治结果。方法：选取我院接收诊治的子宫腺肌病患者30例作为研究样本，对全部患者实施促性腺激素释放激素激动剂联合放置左炔诺孕酮宫内缓释系统治疗方式。结果：应用促性腺激素释放激素激动剂前、放置左炔诺孕酮宫内缓释系统后，患者的痛经程度评分、子宫体积变化情况、血红蛋白水平变化情况、血清CA125水平变化情况等方面对比存在显著性差异（P0.05）。结论：对子宫腺肌病患者应用促性腺激素释放激素激动剂联合放置左炔诺孕酮宫内缓释系统治疗方式实施救治，临床疗效显著，对患者临床表征的改善具有积极作用。 　　【关键词】促性腺激素释放激素激动剂；左炔诺孕酮宫内缓释系统；子宫腺肌病；临床疗效 　　Abstract Objective： To explore the application of uterine adenomyosis patients gonadotropin-releasing hormone agonist joint place left acetylene connaught progesterone intrauterine slow-release system treatment method for treatment of clinical diagnosis and treatment results. Methods： selecting 30 cases of our hospital to receive treatment of uterine adenomyosis patients as the research sample， the full implementation of gonadotropin-releasing hormone agonists in patients with joint place left acetylene connaught progesterone intrauterine slow-release system treatment.Results： application of gonadotropin-releasing hormone agonist placed left acetylene connaught progesterone intrauterine slow-release system， degree of dysmenorrhea score in patients with uterine volume changes Hemoglobin level changes Aspects and so on， the change of the serum CA125 level contrast exists significant difference （P 0.05）. Conclusion： the application in patients with uterine adenomyosis gonadotropin-releasing hormone agonist joint place left acetylene connaught progesterone intrauterine slow-release system treatment method for treatment of clinical curative effect is distinct， plays a positive role on the improvement of the patients with clinical manifestations 　　Key words： gonadotropin-releasing hormone agonist； The slow release system of levonogesterone uterine； Adenomyosis of the uterus； Clinical curative effect 　　【中?D分类号】R711.71 【文献标识码】A 【文章编号】1672-3783（2018）01-03-0-01 　　子宫腺肌病是由于患者子宫内膜细胞与间质细胞发生移位情形，移位至子宫肌层并在子宫肌层实现生长发育过程，子宫腺肌病是致使女性出现不孕症状及妊娠过程中流产的常见因素[1]。本次研究将我院于2014年8月至2017年10月期间接收诊治的子宫腺肌病患者30例作为研